Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Ureteral Neoplasms

NCT06321640 2024-03-20

POSITive

Unknown

265 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

55 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Clinical Trials

Urine DNA Methylation Detection for Hematuria Evaluation

POSITive

VUBAR

Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors

Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS

A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma

18F-LN1 PET/CT in Urothelial Carcinomas

VESUVIO

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study

RADIANT

REGOMUNE

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma

A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder

Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma

Multimodal Spectroscopy to Detect Urothelial Cancer in Urine

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

DEDUCER

Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

TITAN-TCC

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors

RESPONDER

PEBBLE

A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Vasculogenic Mimicry in Urothelial Carcinoma

A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Application of UCAD for Diagnosing Urothelial Carcinoma.

Paclitaxel and TAK-228 in Urothelial Carcinoma

The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer

The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence

FOCUS

iRARC-KSW

PREMIER

BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma

EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells

Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan

DNA Methylation and Urothelial Carcinoma

DNA Methylation and Arsenic-associated Urothelial Carcinoma

The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma

Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma

Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer